News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,685 Results
Type
Article (43613)
Company Profile (314)
Press Release (675758)
Section
Business (211687)
Career Advice (2091)
Deals (36376)
Drug Delivery (94)
Drug Development (82167)
Employer Resources (173)
FDA (16677)
Job Trends (15286)
News (355770)
Policy (33344)
Tag
Academia (2684)
Alliances (52318)
Alzheimer's disease (1323)
Approvals (16644)
Artificial intelligence (209)
Bankruptcy (359)
Best Places to Work (11919)
Biotechnology (222)
Breast cancer (220)
Cancer (1638)
Cardiovascular disease (124)
Career advice (1748)
CAR-T (120)
Cell therapy (342)
Clinical research (65875)
Collaboration (647)
Compensation (337)
COVID-19 (2642)
C-suite (150)
Data (1542)
Diabetes (202)
Diagnostics (6506)
Earnings (86776)
Employer resources (151)
Events (115287)
Executive appointments (554)
FDA (17526)
Funding (585)
Gene therapy (239)
GLP-1 (657)
Government (4454)
Healthcare (19464)
Infectious disease (2746)
Inflammatory bowel disease (117)
Interviews (320)
IPO (16770)
Job creations (3815)
Job search strategy (1490)
Layoffs (443)
Legal (8097)
Lung cancer (243)
Manufacturing (230)
Medical device (13978)
Medtech (13983)
Mergers & acquisitions (19936)
Metabolic disorders (533)
Neuroscience (1715)
NextGen: Class of 2025 (6840)
Non-profit (4612)
Northern California (1973)
Obesity (300)
Opinion (202)
Patents (145)
People (58962)
Phase I (20666)
Phase II (28993)
Phase III (21509)
Pipeline (655)
Postmarket research (2581)
Preclinical (8818)
Radiopharmaceuticals (258)
Rare diseases (310)
Real estate (6222)
Regulatory (22421)
Research institute (2450)
Resumes & cover letters (361)
Southern California (1717)
Startups (3832)
United States (17927)
Vaccines (628)
Weight loss (208)
Date
Today (142)
Last 7 days (638)
Last 30 days (2901)
Last 365 days (35646)
2025 (3106)
2024 (36220)
2023 (41136)
2022 (52397)
2021 (56994)
2020 (55615)
2019 (48410)
2018 (36442)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30243)
2011 (30847)
2010 (28809)
Location
Africa (756)
Arizona (216)
Asia (40108)
Australia (6671)
California (4556)
Canada (1636)
China (380)
Colorado (209)
Connecticut (220)
Europe (87620)
Florida (655)
Georgia (166)
Illinois (462)
Indiana (255)
Maryland (716)
Massachusetts (3551)
Michigan (209)
Minnesota (334)
New Jersey (1289)
New York (1303)
North Carolina (849)
Northern California (1973)
Ohio (167)
Pennsylvania (1057)
South America (1151)
Southern California (1717)
Texas (664)
Utah (138)
Washington State (453)
719,685 Results for "cerveau technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cerveau Technologies Inc. and Prothena Sign Agreement to Provide Novel Tau Imaging Biomarker for Research and Development of Investigational Therapeutics for Neurodegenerative Diseases
Cerveau Technologies, Inc. today announced a research collaboration agreement with Othair Prothena Limited, a subsidiary of Prothena Corporation plc (Prothena), which will enable Prothena to use Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status and progression of neurofibrillary tangles (NFTs) in the brain.
January 10, 2023
·
1 min read
Business
Cerveau Technologies Inc. and LEXEO Therapeutics, Inc.- Sign Agreement to Provide Novel Tau Imaging Biomarker for Disease Modifier Research
Cerveau Technologies, Inc. announced a license agreement with LEXEO Therapeutics, Inc., which will enable LEXEO to use Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography scans to assess the status and progression of neurofibrillary tangles in the brain.
November 7, 2022
·
1 min read
Genetown
Cerveau Technologies Inc. and Alnylam® Pharmaceuticals Sign Agreement to Provide Novel Tau Imaging Biomarker for Disease Modifier Research
Cerveau Technologies, Inc. announced a research collaboration agreement with Alnylam® Pharmaceuticals, which will enable Alnylam to use Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography scans to assess the status and progression of neurofibrillary tangles in the brain.
September 1, 2022
·
1 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Press Releases
Improzo Inc. Revolutionizes Healthcare Consulting With Advanced Technology and Expert Leadership
January 27, 2025
·
5 min read
Business
Cerveau Technologies Inc. Signs Agreement with Roche to Provide Novel Tau Imaging Biomarker for Disease Modifier Research
Cerveau Technologies, Inc. announced a research collaboration agreement with Roche Products Limited, on the use of Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography scans to assess the status and progression of neurofibrillary tangles in the brain.
March 10, 2022
·
1 min read
Press Releases
Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
January 27, 2025
·
2 min read
Press Releases
Healthcare Integrated Technologies, Inc. Promotes Dustin Hillis to President
December 30, 2024
·
2 min read
Press Releases
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
January 28, 2025
·
6 min read
Business
Cerveau Technologies, Inc. and Nihon Med-Physics Co., Ltd. Announce Manufacturing Service Agreement for [18F]MK-6240 in Japan
Cerveau Technologies, Inc. (Cerveau) and Nihon Medi-Physics (NMP), a leading company for radiopharmaceuticals in Japan, today announced that they signed a manufacturing service agreement, in which Cerveau grants NMP the right to manufacture [18F]MK-6240, a next generation investigational Positron Emission Tomography (PET) imaging agent.
February 22, 2022
·
2 min read
1 of 71,969
Next
